Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 151 - 160 of 1824 shown below

  • Kalyandrug, S

    J I Johnson, S Decker, D Zaharevitz, L V Rubinstein, J M Venditti, S Schepartz, S Kalyandrug, M Christian, S Arbuck, M Hollingshead and E A Sausville

    Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

    doi:10.1054/bjoc.2001.1796

  • Kalykaki, A

    J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, A Athanasiadis, S Kakolyris, S Tsousis, Ch Kouroussis, L Vamvakas, A Kalykaki, G Samonis, D Mavroudis and V Georgoulias

    FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic

    advance online publication, 2006-02-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603011

  • V Bozionelou, L Vamvakas, P Pappas, S Agelaki, N Androulakis, A Kalykaki, M Nikolaidou, N Kentepozidis, S Giassas, M Marselos, V Georgoulias and D Mavroudis

    A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

    advance online publication, 2007-06-05 00:00:00.000;

    doi:10.1038/sj.bjc.6603832

  • Kamai, T

    T Kamai, K Takagi, H Asami, Y Ito, H Oshima and K-I Yoshida

    Decreasing of p27Kip1 and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

    doi:10.1054/bjoc.2000.1736

  • Kamakari, S

    S Armaou, M Pertesi, F Fostira, G Thodi, P S Athanasopoulos, S Kamakari, A Athanasiou, H Gogas, D Yannoukakos, G Fountzilas and I Konstantopoulou

    Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases

    advance online publication, 2009-06-02 00:00:00.000;

    doi:10.1038/sj.bjc.6605115

  • Kamanabrou, D

    J Atzpodien, K Neuber, D Kamanabrou, M Fluck, E B Bröcker, C Neumann, T M Rünger, G Schuler, P von den Driesch, I Müller, E Paul, T Patzelt and M Reitz

    Combination chemotherapy with or without s.c. IL-2 and IFN-alpha: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

    doi:10.1038/sj.bjc.6600043

  • Kamangar, F

    A Pourshams, M Saadatian-Elahi, M Nouraie, A F Malekshah, N Rakhshani, R Salahi, A Yoonessi, S Semnani, F Islami, M Sotoudeh, S Fahimi, A R Sadjadi, D Nasrollahzadeh, K Aghcheli, F Kamangar, C C Abnet, F Saidi, V Sewram, P T Strickland, S M Dawsey, P Brennan, P Boffetta and R Malekzadeh

    Golestan cohort study of oesophageal cancer: feasibility and first results

    advance online publication, 2004-12-14 00:00:00.000;

    doi:10.1038/sj.bjc.6602249

  • F Kamangar, Y-L Qiao, M J Blaser, X-D Sun, H Katki, J-H Fan, G I Perez-Perez, C C Abnet, P Zhao, S D Mark, P R Taylor and S M Dawsey

    Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China

    advance online publication, 2006-12-19 00:00:00.000;

    doi:10.1038/sj.bjc.6603517

  • J Koshiol, Y-L Qiao, S D Mark, S M Dawsey, C C Abnet, F Kamangar, E T Lennette, Z-W Dong and P R Taylor

    Epstein–Barr virus serology and gastric cancer incidence and survival

    advance online publication, 2007-11-06 00:00:00.000;

    doi:10.1038/sj.bjc.6604063

  • F Gorouhi, F Islami, H Bahrami and F Kamangar

    Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis

    advance online publication, 2008-03-04 00:00:00.000;

    doi:10.1038/sj.bjc.6604277

  • D Nasrollahzadeh, F Kamangar, K Aghcheli, M Sotoudeh, F Islami, C C Abnet, R Shakeri, A Pourshams, H A Marjani, M Nouraie, M Khatibian, S Semnani, W Ye, P Boffetta, S M Dawsey and R Malekzadeh

    Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604369

  • C C Abnet, N D Freedman, F Kamangar, M F Leitzmann, A R Hollenbeck and A Schatzkin

    Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

    advance online publication, 2009-01-20 00:00:00.000;

    doi:10.1038/sj.bjc.6604880

  • R Malekzadeh, D Nasrollahzadeh and F Kamangar

    Reply: Hookah, opium, and tobacco smoking in relation to ESCC

    advance online publication, 2009-03-03 00:00:00.000;

    doi:10.1038/sj.bjc.6604959

  • F Islami, J-S Ren, P R Taylor and F Kamangar

    Pickled vegetables and the risk of oesophageal cancer: a meta-analysis

    doi:10.1038/sj.bjc.6605372

  • Kamata, Y

    J Watanabe, H Sato, T Kanai, Y Kamata, T Jobo, H Hata, T Fujisawa, E Ohno, T Kameya and H Kuramoto

    Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

    doi:10.1038/sj.bjc.6600434

  • Kamath, K

    C M Galmarini, K Kamath, A Vanier-Viornery, V Hervieu, E Peiller, N Falette, A Puisieux, M Ann Jordan and C Dumontet

    Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

    doi:10.1038/sj.bjc.6600960

  • Kamazawa, S

    R Akeshima, J Kigawa, M Takahashi, T Oishi, Y Kanamori, H Itamochi, M Shimada, S Kamazawa, S Sato and N Terakawa

    Telomerase activity and p53-dependent apoptosis in ovarian cancer cells

    doi:10.1054/bjoc.2001.1812

  • Kamba, T

    T Kamba and D M McDonald

    Mechanisms of adverse effects of anti-VEGF therapy for cancer

    advance online publication, 2007-05-22 00:00:00.000;

    doi:10.1038/sj.bjc.6603813